{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:36:00Z","timestamp":1757622960574,"version":"3.44.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["OZ7552","11C6321N","G099222N","G099222N","G099222N","G099222N"],"award-info":[{"award-number":["OZ7552","11C6321N","G099222N","G099222N","G099222N","G099222N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Athletes often exhibit unexplained non-ischemic myocardial fibrosis, which is associated with malignant arrhythmias. Given the prevalent (over)use of NSAIDs among athletes and their harmful effects during viral myocarditis, this study examined the effects of combined NSAIDs and endurance exercise on the disease progression. To this end, male C57BL\/6J mice underwent eight weeks of treadmill running (60\u00a0min\/day; 18\u00a0cm\/s) or no exercise. After two weeks, mice were implanted with mini-pumps delivering ibuprofen (70\u00a0mg\/kg bw\/day) or vehicle. Myocarditis was induced via intraperitoneal coxsackievirus inoculation. Mice were sacrificed six weeks post-inoculation for ventricular arrhythmogenicity evaluation and cardiac histopathological and molecular analysis. Exercising coxsackievirus-infected mice receiving ibuprofen recovered faster from weight loss. Mortality was low and similar across groups. Histopathology revealed abating inflammation and cell loss, without significant group differences. While exercise tended to increase extensive myocardial fibrosis, statistical analyses indicated no significant differences\u2014with or without NSAIDs\u2014in perivascular fibrosis, interstitial fibrosis, or myocardial scarring. NSAIDs\u2014irrespective of exercise\u2014did not increase arrhythmogenicity. In conclusion, ibuprofen in exercising mice with viral myocarditis resulted in faster weight loss recovery, without significant differences in inflammation, fibrosis, or arrhythmogenesis compared to exercise-only mice.<\/jats:p>","DOI":"10.1038\/s41598-025-13437-x","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T21:18:27Z","timestamp":1755033507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of NSAIDs and endurance exercise on myocardial fibrosis and arrhythmogenesis in murine coxsackieviral myocarditis"],"prefix":"10.1038","volume":"15","author":[{"given":"Sander","family":"Eens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasper","family":"Favere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon","family":"Van Hecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siel","family":"Van den Bogaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Fransen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Roskams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter-Jan","family":"Guns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hein","family":"Heidbuchel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"13437_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fphys.2017.00238","volume":"8","author":"T Liu","year":"2017","unstructured":"Liu, T. et al. Current Understanding of the pathophysiology of myocardial fibrosis and its quantitative assessment in heart failure. Front. Physiol. 8, 238 (2017).","journal-title":"Front. Physiol."},{"issue":"7","key":"13437_CR2","doi-asserted-by":"publisher","first-page":"e004229","DOI":"10.1161\/CIRCEP.116.004229","volume":"9","author":"A Zorzi","year":"2016","unstructured":"Zorzi, A. et al. Nonischemic left ventricular Scar as a substrate of Life-Threatening ventricular arrhythmias and sudden cardiac death in competitive athletes. Circ. Arrhythm. Electrophysiol. 9 (7), e004229 (2016).","journal-title":"Circ. Arrhythm. Electrophysiol."},{"issue":"6","key":"13437_CR3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1093\/eurheartj\/ehy713","volume":"40","author":"SM Shanbhag","year":"2019","unstructured":"Shanbhag, S. M. et al. Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults. Eur. Heart J. 40 (6), 529\u2013538 (2019).","journal-title":"Eur. Heart J."},{"issue":"15","key":"13437_CR4","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.3390\/jcm13154536","volume":"13","author":"RP Allwood","year":"2024","unstructured":"Allwood, R. P., Papadakis, M. & Androulakis, E. Myocardial fibrosis in young and veteran athletes: evidence from a systematic review of the current literature. J. Clin. Med. 13 (15), 4536 (2024).","journal-title":"J. Clin. Med."},{"issue":"8","key":"13437_CR5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/clc.23360","volume":"43","author":"LA Malek","year":"2020","unstructured":"Malek, L. A. & Bucciarelli-Ducci, C. Myocardial fibrosis in athletes-Current perspective. Clin. Cardiol. 43 (8), 882\u2013888 (2020).","journal-title":"Clin. Cardiol."},{"key":"13437_CR6","doi-asserted-by":"crossref","unstructured":"van de Schoor, F. R. et al. Myocardial fibrosis in athletes. Mayo Clin. Proc. 91 (11), 1617\u20131631 (2016).","DOI":"10.1016\/j.mayocp.2016.07.012"},{"issue":"2","key":"13437_CR7","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/bjsports-2014-094546","volume":"50","author":"F Schnell","year":"2016","unstructured":"Schnell, F. et al. Subepicardial delayed gadolinium enhancement in asymptomatic athletes: let sleeping dogs lie? Br. J. Sports Med. 50 (2), 111\u2013117 (2016).","journal-title":"Br. J. Sports Med."},{"key":"13437_CR8","doi-asserted-by":"publisher","first-page":"131382","DOI":"10.1016\/j.ijcard.2023.131382","volume":"394","author":"W Javed","year":"2024","unstructured":"Javed, W., Malhotra, A. & Swoboda, P. Cardiac magnetic resonance assessment of athletic myocardial fibrosis; benign bystander or malignant marker? Int. J. Cardiol. 394, 131382 (2024).","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"13437_CR9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/CIRCRESAHA.115.306573","volume":"118","author":"G Fung","year":"2016","unstructured":"Fung, G., Luo, H., Qiu, Y., Yang, D. & McManus, B. Myocarditis Circ. Res. 118(3), 496\u2013514 (2016).","journal-title":"Myocarditis Circ. Res."},{"issue":"10","key":"13437_CR10","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1056\/NEJM200003093421003","volume":"342","author":"RE McCarthy","year":"2000","unstructured":"McCarthy, R. E. et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl. J. Med. 342 (10), 690\u2013695 (2000).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"13437_CR11","doi-asserted-by":"publisher","first-page":"12653","DOI":"10.1038\/s41598-024-61874-x","volume":"14","author":"K Favere","year":"2024","unstructured":"Favere, K. et al. The influence of endurance exercise training on myocardial fibrosis and arrhythmogenesis in a coxsackievirus B3 myocarditis mouse model. Sci. Rep. 14 (1), 12653 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"13437_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/ijpp.12469","volume":"27","author":"WE Rudgard","year":"2019","unstructured":"Rudgard, W. E., Hirsch, C. A., Rosenbloom, C. & Cox, A. R. Amateur endurance athletes\u2019 use of non-steroidal anti-inflammatory drugs: a cross-sectional survey. Int. J. Pharm. Pract. 27 (1), 105\u2013107 (2019).","journal-title":"Int. J. Pharm. Pract."},{"issue":"8","key":"13437_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1136\/bjsm.2006.027342","volume":"40","author":"G Lippi","year":"2006","unstructured":"Lippi, G., Franchini, M., Guidi, G. C. & Kean, W. F. Non-steroidal anti-inflammatory drugs in athletes. Br. J. Sports Med. 40 (8), 661\u2013662 (2006). discussion 2\u20133.","journal-title":"Br. J. Sports Med."},{"issue":"1","key":"13437_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3810\/psm.2010.04.1770","volume":"38","author":"SJ Warden","year":"2010","unstructured":"Warden, S. J. Prophylactic use of NSAIDs by athletes: a risk\/benefit assessment. Phys. Sportsmed. 38 (1), 132\u2013138 (2010).","journal-title":"Phys. Sportsmed."},{"issue":"13","key":"13437_CR15","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2165\/00002018-200326130-00005","volume":"26","author":"C Meune","year":"2003","unstructured":"Meune, C., Spaulding, C., Mahe, I., Lebon, P. & Bergmann, J. F. Risks versus benefits of NSAIDs including aspirin in myocarditis: a review of the evidence from animal studies. Drug Saf. 26 (13), 975\u2013981 (2003).","journal-title":"Drug Saf."},{"issue":"4","key":"13437_CR16","doi-asserted-by":"publisher","first-page":"H763","DOI":"10.1152\/ajpheart.00337.2022","volume":"323","author":"K Favere","year":"2022","unstructured":"Favere, K. et al. Cardiac electrophysiology studies in mice via the transjugular route: a comprehensive practical guide. Am. J. Physiol. Heart Circ. Physiol. 323 (4), H763\u2013H73 (2022).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"2","key":"13437_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.5740\/jaoacint.11-414","volume":"97","author":"B Yilmaz","year":"2014","unstructured":"Yilmaz, B. & Erdem, A. F. Determination of ibuprofen in human plasma and urine by gas chromatography\/mass spectrometry. J. AOAC Int. 97 (2), 415\u2013420 (2014).","journal-title":"J. AOAC Int."},{"key":"13437_CR18","doi-asserted-by":"crossref","unstructured":"Favere, K. et al. The natural history of CVB3 myocarditis in C57BL\/6J mice: an extended in-depth characterization. Cardiovasc. Pathol. 107652. (2024).","DOI":"10.1016\/j.carpath.2024.107652"},{"issue":"3","key":"13437_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0531-5565(95)02032-2","volume":"31","author":"V Schefer","year":"1996","unstructured":"Schefer, V. & Talan, M. I. Oxygen consumption in adult and AGED C57BL\/6J mice during acute treadmill exercise of different intensity. Exp. Gerontol. 31 (3), 387\u2013392 (1996).","journal-title":"Exp. Gerontol."},{"issue":"5","key":"13437_CR20","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/S0735-1097(85)80312-0","volume":"6","author":"MR Costanzo-Nordin","year":"1985","unstructured":"Costanzo-Nordin, M. R., Reap, E. A., O\u2019Connell, J. B., Robinson, J. A. & Scanlon, P. J. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis. J. Am. Coll. Cardiol. 6 (5), 1078\u20131082 (1985).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"13437_CR21","first-page":"393","volume":"107","author":"S Rezkalla","year":"1986","unstructured":"Rezkalla, S., Khatib, G. & Khatib, R. Coxsackievirus B3 murine myocarditis: deleterious effects of nonsteroidal anti-inflammatory agents. J. Lab. Clin. Med. 107 (4), 393\u2013395 (1986).","journal-title":"J. Lab. Clin. Med."},{"issue":"1","key":"13437_CR22","first-page":"118","volume":"112","author":"S Rezkalla","year":"1988","unstructured":"Rezkalla, S. et al. Effect of indomethacin in the late phase of coxsackievirus myocarditis in a murine model. J. Lab. Clin. Med. 112 (1), 118\u2013121 (1988).","journal-title":"J. Lab. Clin. Med."},{"issue":"1","key":"13437_CR23","first-page":"116","volume":"116","author":"R Khatib","year":"1990","unstructured":"Khatib, R., Reyes, M. P., Smith, F., Khatib, G. & Rezkalla, S. Enhancement of coxsackievirus B4 virulence by indomethacin. J. Lab. Clin. Med. 116 (1), 116\u2013120 (1990).","journal-title":"J. Lab. Clin. Med."},{"issue":"2","key":"13437_CR24","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/00000441-199202000-00006","volume":"303","author":"R Khatib","year":"1992","unstructured":"Khatib, R. et al. Focal ventricular thinning caused by indomethacin in the late phase of coxsackievirus B4 murine myocarditis. Am. J. Med. Sci. 303 (2), 95\u201398 (1992).","journal-title":"Am. J. Med. Sci."},{"key":"13437_CR25","doi-asserted-by":"publisher","first-page":"115813","DOI":"10.1016\/j.bcp.2023.115813","volume":"217","author":"TD Bryson","year":"2023","unstructured":"Bryson, T. D. & Harding, P. Prostaglandin E2 and myocarditis; friend or foe? Biochem. Pharmacol. 217, 115813 (2023).","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"13437_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ymeth.2006.07.009","volume":"41","author":"D Fairweather","year":"2007","unstructured":"Fairweather, D. & Rose, N. R. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41 (1), 118\u2013122 (2007).","journal-title":"Methods"},{"issue":"7","key":"13437_CR27","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.molmed.2012.05.005","volume":"18","author":"MF Corsten","year":"2012","unstructured":"Corsten, M. F., Schroen, B. & Heymans, S. Inflammation in viral myocarditis: friend or foe? Trends Mol. Med. 18 (7), 426\u2013437 (2012).","journal-title":"Trends Mol. Med."},{"issue":"9","key":"13437_CR28","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1001\/jamacardio.2021.2065","volume":"6","author":"CJ Daniels","year":"2021","unstructured":"Daniels, C. J. et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 6 (9), 1078\u20131087 (2021).","journal-title":"JAMA Cardiol."},{"issue":"5","key":"13437_CR29","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/0735-1097(93)90254-X","volume":"21","author":"S Zhang","year":"1993","unstructured":"Zhang, S. et al. Effects of cyclosporine, prednisolone and aspirin on rat autoimmune giant cell myocarditis. J. Am. Coll. Cardiol. 21 (5), 1254\u20131260 (1993).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"13437_CR30","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2459\/JCM.0b013e328351da6e","volume":"14","author":"A Buiatti","year":"2013","unstructured":"Buiatti, A. et al. Clinical presentation and long-term follow-up of perimyocarditis. J. Cardiovasc. Med. (Hagerstown). 14 (3), 235\u2013241 (2013).","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"1","key":"13437_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.113.001531","volume":"128","author":"M Imazio","year":"2013","unstructured":"Imazio, M. et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation 128 (1), 42\u201349 (2013).","journal-title":"Circulation"},{"issue":"11","key":"13437_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1161\/CIRCULATIONAHA.118.035319","volume":"138","author":"E Ammirati","year":"2018","unstructured":"Ammirati, E. et al. Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: multicenter Lombardy registry. Circulation 138 (11), 1088\u20131099 (2018).","journal-title":"Circulation"},{"issue":"1","key":"13437_CR33","doi-asserted-by":"publisher","first-page":"e000990","DOI":"10.1136\/openhrt-2018-000990","volume":"6","author":"J Berg","year":"2019","unstructured":"Berg, J. et al. Non-steroidal anti-inflammatory drug use in acute myopericarditis: 12-month clinical follow-up. Open. Heart. 6 (1), e000990 (2019).","journal-title":"Open. Heart"},{"key":"13437_CR34","doi-asserted-by":"crossref","unstructured":"Mirna, M. et al. Treatment with Non-Steroidal Anti-Inflammatory drugs (NSAIDs) does not affect outcome in patients with acute myocarditis or myopericarditis. J. Cardiovasc. Dev. Dis. ;9(2). (2022).","DOI":"10.3390\/jcdd9020032"},{"key":"13437_CR35","doi-asserted-by":"crossref","unstructured":"Pham, H. & Spaniol, F. The efficacy of Non-Steroidal Anti-Inflammatory drugs in athletes for injury management, training response, and athletic performance: A systematic review. Sports (Basel) ;12(11). (2024).","DOI":"10.3390\/sports12110302"},{"issue":"3","key":"13437_CR36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jsams.2024.11.010","volume":"28","author":"D Fitzpatrick","year":"2025","unstructured":"Fitzpatrick, D., Leckie, T., Heine, G. & Hodgson, L. The use of pain killers (NSAIDs) in athletes: how large is the risk? J. Sci. Med. Sport. 28 (3), 198\u2013205 (2025).","journal-title":"J. Sci. Med. Sport"},{"issue":"3","key":"13437_CR37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/eurjpc\/zwab198","volume":"29","author":"PE Adami","year":"2022","unstructured":"Adami, P. E. et al. Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise nucleus of the European association of preventive cardiology. Eur. J. Prev. Cardiol. 29 (3), 559\u2013575 (2022).","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"2","key":"13437_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00003677-200504000-00002","volume":"33","author":"TJ Hawke","year":"2005","unstructured":"Hawke, T. J. Muscle stem cells and exercise training. Exerc. Sport Sci. Rev. 33 (2), 63\u201368 (2005).","journal-title":"Exerc. Sport Sci. Rev."},{"issue":"2","key":"13437_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1152\/japplphysiol.00157.2007","volume":"103","author":"AL Mackey","year":"2007","unstructured":"Mackey, A. L. et al. The influence of anti-inflammatory medication on exercise-induced myogenic precursor cell responses in humans. J. Appl. Physiol. (1985). 103 (2), 425\u2013431 (2007).","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"5","key":"13437_CR40","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1152\/japplphysiol.00707.2009","volume":"107","author":"UR Mikkelsen","year":"2009","unstructured":"Mikkelsen, U. R. et al. Local NSAID infusion inhibits satellite cell proliferation in human skeletal muscle after eccentric exercise. J. Appl. Physiol. (1985). 107 (5), 1600\u20131611 (2009).","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"1","key":"13437_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/eurheartj\/ehaa605","volume":"42","author":"A Pelliccia","year":"2020","unstructured":"Pelliccia, A. et al. 2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease: the task force on sports cardiology and exercise in patients with cardiovascular disease of the European society of cardiology (ESC). Eur. Heart J. 42 (1), 17\u201396 (2020).","journal-title":"Eur. Heart J."},{"issue":"23","key":"13437_CR42","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1136\/hrt.2008.164061","volume":"95","author":"MS Cocker","year":"2009","unstructured":"Cocker, M. S., Abdel-Aty, H., Strohm, O. & Friedrich, M. G. Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study. Heart 95 (23), 1925\u20131930 (2009).","journal-title":"Heart"},{"key":"13437_CR43","doi-asserted-by":"publisher","first-page":"1129348","DOI":"10.3389\/fcvm.2023.1129348","volume":"10","author":"D Fairweather","year":"2023","unstructured":"Fairweather, D. et al. Sex and gender differences in myocarditis and dilated cardiomyopathy: an update. Front. Cardiovasc. Med. 10, 1129348 (2023).","journal-title":"Front. Cardiovasc. Med."},{"issue":"11","key":"13437_CR44","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/eurheartj\/ehm076","volume":"28","author":"AL Caforio","year":"2007","unstructured":"Caforio, A. L. et al. A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur. Heart J. 28 (11), 1326\u20131333 (2007).","journal-title":"Eur. Heart J."},{"issue":"1","key":"13437_CR45","doi-asserted-by":"publisher","first-page":"10742","DOI":"10.1038\/s41598-018-29050-0","volume":"8","author":"AS Aguiar Jr","year":"2018","unstructured":"Aguiar, A. S. Jr., Speck, A. E., Amaral, I. M., Canas, P. M. & Cunha, R. A. The exercise sex gap and the impact of the estrous cycle on exercise performance in mice. Sci. Rep. 8 (1), 10742 (2018).","journal-title":"Sci. Rep."},{"issue":"10","key":"13437_CR46","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16 (10), 626\u2013638 (2016).","journal-title":"Nat. Rev. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13437-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13437-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T01:35:55Z","timestamp":1757381755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13437-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13437"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13437-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,8,12]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29607"}}